Compare IH & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | SEER |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 98.2M |
| IPO Year | 2020 | 2020 |
| Metric | IH | SEER |
|---|---|---|
| Price | $2.05 | $2.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.9K | ★ 235.0K |
| Earning Date | 03-24-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $119,261,855.00 | $16,376,999.00 |
| Revenue This Year | $39.02 | $22.37 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | ★ 12.11 |
| 52 Week Low | $1.76 | $1.62 |
| 52 Week High | $3.60 | $2.41 |
| Indicator | IH | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 58.66 |
| Support Level | $1.95 | $1.70 |
| Resistance Level | $2.24 | $1.84 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 59.14 | 97.96 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.